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Abstract 33 
Objectives: Chronic cardiovascular diseases, cancer, chronic respiratory diseases and diabetes 34 
are the four major groups of non-communicable diseases (NCDs) and the main cause of 35 
mortality worldwide. Pilates has been described as an effective intervention to promote 36 
healthy behaviors and physical activity in people with chronic diseases. However, the evidence 37 
of its effects in NCDs have not been systematized. We investigated the effects of Pilates in the 38 
four major groups of NCDs. Design: A systematic review was performed. Searches were 39 
conducted on Cochrane Library, EBSCO, PubMed, Science Direct, Scopus and Web of Science 40 
databases. Studies were rated with the quality assessment tool for quantitative studies. As a 41 
meta-analysis was not possible to conduct, a best-evidence synthesis was used.  42 
Results: Twelve studies, mostly of moderate quality, were included with 491 participants 43 
(78.6% females; age range 13.7-70 years old) with breast cancer (n=3), diabetes (n=3), chronic 44 
stroke (2 years post stroke) (n=2), chronic obstructive pulmonary disease (n=1), cystic fibrosis 45 
(n=1), heart failure (n=1) and arterial hypertension (n=1). The best-evidence synthesis 46 
revealed strong evidence for improving exercise tolerance; moderate evidence for improving 47 
symptoms, muscle strength and health-related quality of life and limited or conflicting 48 
evidence on vital signs, metabolic parameters, body composition, respiratory function, 49 
functional status, balance, flexibility and social support.  50 
Conclusions: Pilates should be considered for patients with NCDs, as it improves exercise 51 
tolerance. Future studies with robust methodologies are still needed to clarify its effectiveness 52 
on outcomes with moderate, limited or conflicting evidence and to establish the most suitable 53 
intervention protocol. 54 
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1. Introduction 65 
Noncommunicable diseases (NCDs) are the main cause of mortality worldwide and derive in 66 
substantial socioeconomic burden, entailing thousands of years lived with disability1-3. Chronic 67 
cardiovascular diseases, cancer, chronic respiratory diseases and diabetes are the four major 68 
groups of NCDs, accounting for 82% of all NCDs’ deaths4-7. These diseases are associated with 69 
modifiable risk factors, such as cigarette smoking, hypertension, dyslipidaemia, obesity, 70 
physical inactivity and poor nutrition, and could be prevented or controlled by adopting a 71 
healthy lifestyle8-11. Pilates has been described as an effective intervention to improve physical 72 
activity levels and healthy behaviours, emerging as a novel intervention for the treatment of 73 
chronic diseases12.  74 
Pilates was created by Joseph Pilates in the 1920s and its philosophy relies on the tenet 75 
“balance of body and mind”13. It is a versatile exercise that covers six principles: centring, 76 
concentration, control, precision, flow and breathing14. Pilates has gained popularity through 77 
the years for its benefits on muscle endurance, flexibility and dynamic balance in healthy 78 
people15, and its ability to improve pain, function and kinesiophobia in people with disability 79 
(e.g., patients with chronic low back pain)16. Moreover, recent studies suggest that this 80 
intervention has potential to maximize the physical and mental health of people living with 81 
NCDs17-20. However, the evidence of Pilates in these conditions has never been systematized. 82 
Therefore, this review aimed to investigate the effects of Pilates in the four major groups of 83 
NCDs – chronic cardiovascular diseases, cancer, chronic respiratory diseases and diabetes. 84 
 85 
2. Material and Methods 86 
2.1 Study Design 87 
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This systematic review was followed the preferred reporting items for systematic 88 
reviews and meta-analyses (PRISMA) guidelines21. The protocol was registered in the 89 
international prospective register of systematic reviews (PROSPERO) (ID: CRD42016050050).  90 
 91 
2.2 Search strategy 92 
Preliminary searches were first conducted in the Cochrane Library and PROSPERO to exclude 93 
the existence of a similar review. A comprehensive systematic search was then conducted in 94 
the following electronic databases: Cochrane Library (1999-2017), EBSCO (1974-2017), 95 
PubMed (1996-2017), Science Direct (1997-2017), Scopus (1960-2017) and Web of Science 96 
(1900-2017) on the 15th of November 2016. Additional searches were performed in weekly 97 
automatic updates retrieved from the databases until November 2017. The detailed search 98 
can be found on appendix 1. The references of the included studies and key reviews were 99 
hand searched for potentially eligible studies. 100 
 101 
2.3 Eligibility Criteria 102 
Studies were considered eligible if (1) included participants with the most common NCDs, i.e., 103 
chronic respiratory diseases, chronic cardiovascular diseases, cancer or diabetes; (2) described 104 
any Pilates intervention and (3) reported at least one clinical or patient-reported outcome. 105 
Searches were restricted to studies published in English, Spanish, French and Portuguese. 106 
Studies were excluded if they referred only proxy versions of the outcome measures. 107 
Guidelines, systematic reviews, qualitative studies, news, research protocols, theses, 108 
dissertations, abstracts, letters to the editor and unpublished work were also excluded, 109 
although their references were searched for relevant articles. 110 
 111 
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2.4 Selection of studies 112 
One author screened each article for type of publication and relevance for the scope of the 113 
review, according to their title, abstract and keywords. If this information suggested that the 114 
study could fit the inclusion criteria of the systematic review, the full article was further 115 
assessed. The full-text of each potentially relevant study was screened for its content and in 116 
cases of uncertainty, the decision to include/exclude the study was debated between two 117 
reviewers until reaching consensus.  118 
 119 
2. 5 Data extraction 120 
One reviewer extracted the data to two pre-developed and structured tables (i.e., clinical and 121 
patient-reported outcomes). Data extracted were: author’s name, year and country of 122 
publication, study design, participants’ characteristics (i.e., health condition, percentage of 123 
males, age) type of intervention(s) or comparator(s), measures and outcomes used and 124 
quantitative findings. Two reviewers checked the extracted data for accuracy and 125 
completeness. Reviewers resolved disagreements by consensus. Authors of the included 126 
studies were contacted for missing data. 127 
 128 
2.6 Quality Assessment 129 
The methodological quality of the included studies was assessed by two independent 130 
reviewers using the quality assessment tool for quantitative studies22. This tool, developed by 131 
the effective public health practice project (EPHPP), is composed of eight sections: 1) selection 132 
bias; 2) study design; 3) confounders; 4) blinding; 5) data collection methods; 6) withdrawals 133 
and dropouts; 7) intervention integrity and 8) analysis. The overall methodology of studies is 134 
rated as strong (no weak ratings in all sections), moderate (one weak rating) or weak (two or 135 
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more weak ratings)22. Agreement was reached by consensus between the two independent 136 
reviewers. 137 
 138 
2.7 Data analysis 139 
Inter-rater agreement of the quality assessment was explored using Cohen’s kappa. The value 140 
of Cohen’s kappa was interpreted as i) <0: poor agreement; ii) 0.00-0.20: slight agreement; iii) 141 
0.21-0.40: fair agreement; iv) 0.41-0.60: moderate agreement; 0.61-0.80: substantial 142 
agreement; vi) 0.81-1.00: almost perfect agreement23.  143 
Due to the diversity of the outcome measures used in the selected studies, a meta-analysis 144 
was not possible to conduct. Instead, a summary of the results was performed using a best-145 
evidence synthesis24 (Table 4). This analysis considered the number, methodological quality 146 
and consistency of outcomes of the studies, using 5 levels of evidence: (1) strong evidence, 147 
provided by consistent findings among multiple (≥2) high quality randomized controlled trials 148 
(RCTs); (2) moderate evidence, provided by consistent findings among multiple low quality 149 
RCTs and/or non-randomized controlled clinical trials (CCTs) and/or one high quality RCT; (3) 150 
limited evidence, provided by only one low quality RCT and/or CCT; (4) conflicting evidence, 151 
provided by inconsistent findings among multiple trials (RCTs and/or CCTs) and (5) no 152 
evidence, when no RCTs or CCTs are found25. 153 
Effect sizes (ES) for each outcome measure were calculated using comprehensive meta-154 
analysis (CMA) software (Biostat, Englewood, New Jersey)26 and interpreted as small 155 
(0.2≤d<0.5), medium (0.5≤d<0.8) and large (d≥0.8)27.  156 
 157 
3. Results 158 
3.1 Study selection 159 
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The databases search identified 676 studies and 11 additional studies were found through key 160 
reviews. After duplicates removal, 482 studies were screened for potential content. During 161 
the title, abstract and keyword screening, 423 articles were excluded. The full-text of 59 162 
potentially relevant articles was assessed and 47 articles were excluded due to the following 163 
reasons: i) full-text was not available28; ii) population included diseases other than chronic 164 
cardiovascular, chronic respiratory, cancer and diabetes29-36; iii) type of intervention was not 165 
Pilates37-58; iv) type of study was a qualitative study, news, research protocol or letters to the 166 
editor7, 10, 59-64,65 and v) study was not written in English, Spanish, French or Portuguese 167 
languages66-69. Twelve studies were included. A detailed flow diagram of the review process is 168 
presented in figure 1. 169 
 170 
3.2 Quality Assessment 171 
From the articles included in this review, eight scored moderate70-77, three scored strong78-80 172 
and one scored weak81 quality (Table 1). The agreement between the two reviewers was 173 
almost perfect (k=0.84; 95%CI [0.38–1]). 174 
 175 
3.3 Study characteristics 176 
Studies varied in their design. Nine were RCTs70-72, 74, 77-81 and three were pre-post design73, 75, 177 
76. A total of 491 participants (78.6% females; age range 13.7-70 years old) were recruited 178 
among studies conducted in breast cancer70, 71, 79, diabetes74, 75, 81, chronic stroke (2 years post 179 
stroke)77, 80, chronic obstructive pulmonary disease (COPD)72, cystic fibrosis73, heart failure78 180 
and arterial hypertension76. 181 
Generally, the interventions ranged from 8 to 16 weeks, with a frequency of 1 to 3 times per 182 
week and each session lasted between 40 and 90 minutes. Five studies had additional 183 
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exercises (i.e., walking and swimming) included in their intervention70, 77-80 and one study 184 
delivered an educational session70. Some of the studies reporting usual care as a comparator, 185 
did not provide a clear description of the possible undergoing treatments76, 81. Study 186 
characteristics are presented in Table 2 and Table 3. 187 
 188 
3. 4 Synthesis of the results 189 
3.4.1 Symptoms 190 
Physical symptoms were assessed using  the visual analogue scale (VAS) for pain71, 74, 79 and 191 
fatigue74, brief fatigue inventory for fatigue70, social appearance anxiety scale (SAA) for 192 
anxiety79, the hospital anxiety and depression scale (HADS)74 for anxiety and depression, 193 
Beck’s depression inventory (BDI) for depression70, and the 36-item short form survey (SF-194 
36)74 and the 28-item general health questionnaire (GHQ-28) for physical symptoms globally75.  195 
Significant improvements were reported for pain (p=0.001-0.01, ES=-12.70--0.27)74, 75, fatigue 196 
(p=0.001, ES=-0.25)74, anxiety (p=0.04-0.023, ES=0.0-1.52) and depression  symptoms 197 
(p=0.019-0.01, ES= 0.0--1.38)74, 75 and general mental health (p=0.001, ES=0.0)74 in patients 198 
with type 2 diabetes. Significant improvements were also observed for pain (p=0.004-0.01, 199 
ES=0.0-0.4)71, 79 and anxiety (p<0.01 ES=-0.4)79 and depression (p=0.01, ES=-0.09)70 in patients 200 
with breast cancer however, no differences between groups were reported. In the best-201 
evidence synthesis analysis, moderate evidence was found (Table 4). 202 
 203 
3.4.2 Vital signs  204 
A variety of vital signs using different equipment have been assessed in Pilates interventions, 205 
namely peripheral oxygen saturation (SpO2) with oximetry72; heart rate at rest with 206 
electrocardiogram during cardiopulmonary exercise testing (CPET)78, 80 or an oscillometric 207 
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device76; respiratory rate with plethysmography72 and blood pressure with the auscultation 208 
method during CPET [14] and an oscillometric device76, 78.  209 
Peripheral oxygen saturation increased significantly (p<0.05, ES=0.16) with Pilates breathing 210 
when compared to natural breathing, although diaphragmatic breathing was found to be even 211 
of more benefit72. Respiratory rate increased significantly (p<0.05, ES=0.12) with Pilates 212 
breathing in patients with COPD when compared to diaphragmatic breathing. Results also 213 
improved significantly for diastolic blood pressure (DBP) of patients with heart failure (p=0.02, 214 
ES=-0.24)78 and for both DBP (p<0.05, ES= -0.35) and systolic blood pressure (SBP) (p<0.05, 215 
ES=-0.59) in patients with arterial hypertension76; though no differences were found in 216 
patients with COPD when compared to controls72.  Conflicting results were however found for 217 
heart rate, as no differences were reported in patients with heart failure (p>0.05, ES=-0.05)78 218 
and arterial hypertension (p>0.05, ES=-0.26)76 while significant improvements (i.e., reduced 219 
heart rate) were observed in patients with chronic stroke (p<0.05, ES=-0.49)80. The overall 220 
analysis of best-evidence synthesis on vital signs showed conflicting evidence (Table 4). 221 
 222 
3.4.3 Metabolic parameters 223 
Glycated hemoglobin (Hba1c), daily insulin doses (DID), high density lipoprotein (HDL), high 224 
density lipoprotein (LDL), total cholesterol (T col) and triglyceride (TG) were assessed through 225 
metabolic analysis of patients with type 1 diabetes81. No significant improvements were 226 
reported for the experimental group (EG) (p>0.05) whereas in the control group (CG) a 227 
significant improvement was reported in HDL (p=0.046, ES=-0.14)81. As only one study 228 
assessed this outcome, limited evidence on the best-evidence synthesis analysis was found 229 
(Table 4). 230 
 231 
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3.4.4 Body composition 232 
Body mass (BM), body mass index (BMI), waist and hip circumferences were assessed using 233 
calculations and an anthropometric tape in patients with arterial hypertension76. Significant 234 
improvements were only found in waist (p<0.05, ES=-0.27) and hip circumferences (p<0.05, 235 
ES=-0.31)76. Similarly, to metabolic parameters, the evidence presented in the best-evidence 236 
synthesis was also limited (Table 4). 237 
 238 
3.4.5 Muscle strength 239 
Upper71, 76, 79, lower limb81 and respiratory73 muscle strength was assessed. The lower limb 240 
was assessed with the vertical jump test and the modified Wingate test for anaerobic 241 
capacity81, the upper limb with the hand-held dynamometer71 and the handgrip 242 
dynamometer71, 76, 79 and respiratory muscle strength with a pressure manometer in patients 243 
with breast cancer71, 79, arterial hypertension76, type 1 diabetes81 and cystic fibrosis73.  244 
Shoulder strength was found to improve significantly during flexion (p=0.019, ES=0.14), 245 
abduction (p=0.001, ES=0.10), internal (p=0.015, ES=0.10) and external rotation, (p=0.017, 246 
ES=0.10) in patients with breast cancer without differences between groups71. Significant 247 
improvements in handgrip strength (p=0.01-0.49, ES=0.14-0.63) in both patients with breast 248 
cancer71, 79 and arterial hypertension were also reported76.  249 
In patients with type 1 diabetes, significant improvements in lower limb strength were 250 
reported, particularly in jump height (p=0.003, ES=0.15), mean power (p<0.001, ES=0.10) and 251 
peak power (p=0.02, ES=0.20)81.  252 
Regarding respiratory muscle strength, significant improvements in maximum inspiratory 253 
pressure (MIP) in both male (p=0.017, ES=0.11) and female (p=0.005, ES=1.19) patients were 254 
reported, while maximum expiratory pressure (MEP) only improved in female patients 255 
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(p=0.007, ES=0.87)73. Moderate evidence in the best-evidence synthesis analysis was found 256 
(Table 4). 257 
 258 
3.4.6 Respiratory function 259 
Respiratory pattern was assessed using inductive plethysmography in patients with COPD and 260 
healthy people72 and lung volumes were assessed using spirometry in patients with cystic 261 
fibrosis73.  262 
Significant differences in favor of diaphragmatic breathing, rather than Pilates in inspiratory 263 
(p<0.05, ES=0.87), expiratory volumes (p<0.05, ES=1.20)  and phase angle (p<0.05, ES=0.86) 264 
were reported72. No significant changes were found in forced expiratory volume in one second 265 
(FEV1) or forced vital capacity (FVC), both in male (p=0.598, ES=0.10; p=0.555, ES=0.09) and 266 
female patients (p=0.463, ES=0.08; p=0.964, ES=0.05)73. The best-evidence analysis presented 267 
limited evidence (Table 4). 268 
 269 
3.4.7 Functional status 270 
This outcome was assessed using the constant-Murley score71 and the disabilities of the arm, 271 
shoulder, and hand scale (DASH)79 in patients with breast cancer, and the timed up and go test  272 
(TUG) in chronic stroke patients80. Significant improvements were reported in patients with 273 
breast cancer (p<0.01, ES=0.21-0.24)71, 79 and in chronic stroke patients (p<0.05, ES=-0.82)80, 274 
though in one of the studies on patients with breast cancer no differences between groups 275 
were found79. The best-evidence synthesis presented conflicting evidence for functional 276 
status (Table 4). 277 
 278 
3.4.8 Exercise tolerance 279 
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Exercise tolerance was assessed using the 6-minute walk test in patients with breast cancer70 280 
and CPET in patients with heart failure and chronic stroke78, 80.  281 
Significant improvements were reported in 6-minute walking distance (6MWD) (p<0.01, 282 
ES=1.28)70, peak oxygen consumption (peak VO2) (p=0.02, ES=0.46-0.53)78,80, pulse O2 283 
(p=0.003, ES=0.35) and time achieved during CPET (p<0.001, ES=0.55)78. No significant 284 
changes regarding respiratory exchange ratio (RER) and minute ventilation (VE/VCO2) were 285 
reported (p>0.05)78. Strong evidence was found in the best-evidence synthesis analysis (Table 286 
4). 287 
 288 
3.4.9 Balance 289 
This outcome was assessed using an instrumented treadmill with force plates in patients with 290 
chronic stroke77. Significant improvements were reported for static balance, specifically in 291 
medial-lateral (p<0.05, ES=-1.36) and anterior-posterior (p<0.05, ES=-0.67) center of pressure 292 
(COP) and medial-lateral (p<0.05, ES=-0.41) and anterior-posterior (p<0.001, ES=-0.42) 293 
velocity. Dynamic balance of both paretic and non-paretic sides also showed significant 294 
improvements in medial-lateral (p<0.05, ES=-1.28 to -1.71) and anterior-posterior (p<0.001, 295 
ES=-1.27--1.71) COP and medial-lateral (p<0.001, ES=-0.3 to -0.43) and anterior-posterior 296 
(p<0.01, ES=-0.46 to -0.53) velocities77. The analysis of best-evidence synthesis presented 297 
limited evidence as only one study assessed this outcome (Table 4). 298 
 299 
3.4.10 Flexibility 300 
Flexibility was assessed with the sit-and-reach test in patients with breast cancer and 301 
diabetes70, 81, the bank of wells test in patients with arterial hypertension76 and range of 302 
motion (ROM) of the shoulder using a goniometer in patients with breast cancer71, 79.  303 
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Significant improvements were reported in patients with diabetes (p<0.001, ES=0.94) 81 and 304 
arterial hypertension76 (p<0.05, ES=0.52), though in patients with breast cancer, one study 305 
found no significant changes70 while others found a significant improvement in shoulder 306 
flexion (p=0.001-0.01; ES=0.16-0.51) and abduction (p=0.002-0.01; ES=0.11-0.38)71, 79. 307 
Regarding external rotation of the shoulder, conflicting results were found, as one of the 308 
studies found a significant improvement (p=0.007, ES=0.21)71 while the other reported no 309 
significant changes (p=0.15)79. In the analysis of best-evidence synthesis, conflicting evidence 310 
was found (Table 4). 311 
 312 
3.4.11 Quality of life  313 
Health-related quality of life (HRQoL) was assessed using the european organization for the 314 
research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30)70, the 315 
european organization for the research and treatment of cancer quality of life questionnaire 316 
breast cancer module 23 (EORTC QLQ-BR23) in patients with breast cancer70, 79 and 36-item 317 
short form survey (SF-36) in patients with diabetes74. 318 
Significant improvements were reported for HRQoL (p=0.03-0.04, ES=0.01-0.53) in patients 319 
with breast cancer (with no differences between groups) (p=0.94)70, 79 and for mental health 320 
HRQoL (p=0.001, ES=0.0) in patients with diabetes74. The best-evidence synthesis presented 321 
moderate evidence for the effects of Pilates on HRQoL (Table 4). 322 
 323 
3.4.12 Social support 324 
Only one study assessed social support using GHQ-28 in patients with type 2 diabetes and a 325 
significant improvement was found (p=0.001, ES=-1.73)75.  326 
The best-evidence synthesis presented limited evidence for social support (Table 4). 327 
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4. Discussion 328 
To the authors’ best knowledge this was the first study to systematically review Pilates effects 329 
across multiple NCDs. 330 
The best-evidence synthesis showed strong evidence for exercise tolerance; moderate 331 
evidence for symptoms, muscle strength and HRQoL; limited evidence for metabolic 332 
parameters, body composition, respiratory function, balance and social support and 333 
conflicting evidence for vital signs, functional status and flexibility; when using Pilates in NCDs. 334 
Overall Pilates had larger effects on diabetes, followed by chronic respiratory and 335 
cardiovascular diseases and cancer. High levels of comorbidities have been reported in 336 
patients with chronic respiratory and cardiovascular diseases and cancer which will affect their 337 
functional capacity, health status and quality of life82-85. Therefore, more comprehensive 338 
Pilates interventions, with longer duration, intensity and adjusted exercises (such as aerobic 339 
training) might be required for people with these NCD. Indeed, the most appropriate Pilates 340 
protocol for each NCD is still to ascertain. Based on the findings of this systematic review, 341 
longer (>8 weeks) interventions with additional components (educational sessions or home 342 
exercises), at least three times a week, seem to be more effective. 343 
Although exercise tolerance was assessed with different outcome measures, its improvement 344 
with Pilates was unequivocal. As improving exercise tolerance is fundamental to manage these 345 
lifestyle-related diseases86, Pilates seems to be an important intervention to be encouraged, 346 
as it is effective and is perceived as a soft and enjoyable approach for patients87, 88. 347 
Nevertheless, the effects of Pilates on exercise tolerance were limited to patients with breast 348 
cancer and cardiovascular diseases and therefore, its effects on other conditions are still 349 
unknown. 350 
 15 
The moderate evidence found for symptoms, muscle strength and HRQoL might be due to the 351 
heterogeneity of the outcome measures used, the wide age range of participants, the 352 
different approaches to Pilates, and/or poor methodologies used by the studies. Nevertheless, 353 
positive effects of Pilates on symptoms, muscle strength and HRQoL were reported in all 354 
studies assessing these outcomes. Given the negative multi-systemic effects (e.g., skeletal 355 
muscle impairment, mood disturbance, hormonal imbalance and immunological 356 
incompetence) inherent to NCDs89-91 and the positive effects of Pilates found in all studies, 357 
research with more robust methodologies is urgently needed. 358 
The limited evidence found on five of the twelve outcomes (metabolic parameters, body 359 
composition, respiratory function, balance and social support) was due to the scarce number 360 
of studies, hampering the assessment of Pilates overall effectiveness. However, few studies 361 
suggested that Pilates was effective in improving body composition, respiratory function, 362 
balance and social support. This is of special importance, since these parameters, are 363 
modifiable factors that can contribute to falls, considered a major public health issue 364 
worldwide92. Moreover, social support has been found to be associated with better health 365 
outcomes,  being a protective factor for mental and physical health93. Although previous 366 
studies have shown improvements on these outcomes with Pilates, they were conducted in 367 
healthy adults and elderly women94-96, with much less known about them in people with NCDs. 368 
Given the social, economic and health burden of NCDs worldwide1, further research using 369 
Pilates on these outcomes seem a priority.    370 
Whilst there was conflicting evidence of the effects of Pilates on vital signs, for some 371 
parameters (i.e., SpO2, DBP and respiratory rate), global positive effects were found in all 372 
studies. Similarly, most studies reported a positive effect on functional status and flexibility, 373 
although there were still few studies reporting no effects with the intervention. Since poor 374 
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functional status is a predictor of mortality, a risk factor for developing emotional disorders 375 
and hospital readmissions97-99, and flexibility might be a predictor of arterial stiffening and 376 
musculotendinous disorders100, the need for additional studies is imperative. 377 
Finally, physical activity and self-efficacy are also fundamental aspects to consider when 378 
treating people with NCDs, as they are strong predictors of HRQoL in these patients101. 379 
Although Pilates is an effective tool for enhancing physical activity in other populations12, this 380 
has not been explored in people with NCDs. Moreover, fundamental everyday behaviours 381 
such as daily-living activities are not being assessed in Pilates interventions. Therefore, new 382 
studies are needed to explore its effects on these outcomes in patients with NCDs. 383 
This systematic review has some limitations. Primarily, the different study designs and 384 
measures used in both patient-reported and clinical outcomes hampered the results’ 385 
synthesis and the conduction of meta-analysis. Nevertheless, the best-evidence synthesis 386 
provided a thorough and unbiased means of synthesizing the research developed, and 387 
provided clear conclusions. Another limitation was the lack of a clear description of usual care 388 
on control groups, which might have led to a poor estimation of the treatment effect inhibiting 389 
its comparison with other interventions. Lastly, samples were mainly composed of female 390 
participants, being inappropriate to generalize the results to both genders. Thus, future 391 
studies should integrate male patients to determine if similar results are found in the whole 392 
spectrum of these populations. 393 
 394 
5. Conclusion 395 
Findings from this show that Pilates improves exercise tolerance and could play an important 396 
role on symptoms, muscle strength and HRQoL of people with NCDs.  397 
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Due to limited or conflicting evidence on other outcomes, future studies with homogeneous 398 
outcome measures across the four major NCDs are needed. 399 
Although the best Pilates protocol for each NCD is yet to ascertain, more comprehensive 400 
interventions, superior to 8 weeks, seem to be more effective. Though additional research is 401 
still needed, Pilates should be taken into account as an adjunct intervention for the treatment 402 
of these patients, as it is an appealing and effective form of exercise. 403 
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Figure 1 - Flow diagram for study selection according to the preferred reporting items for systematic review and meta-analysis 768 
(PRISMA) guidelines 769 
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   1: strong quality; 2: moderate quality; 3: weak quality. 
 
 
 
 
 
 
 
 
Author (year) Selection bias Study design Confounders Blinding 
Data collection 
method 
Withdrawals 
and dropouts 
Global rating 
Tunar et al. (2012) 2 1 3 2 3 1 3 
Eygor et al. (2010) 2 1 1 2 3 2 2 
Zengin et al. (2016) 2 1 3 2 1 1 2 
Sener et al. (2017) 2 1 1 2 1 1 1 
Cancelliero-Gaiad et al. (2014) 3 1 1 2 1 1 2 
Franco et al. (2014) 2 2 3 2 1 2 2 
Guimarães et al. (2012) 2 1 1 2 1 1 1 
Martins-Meneses et al. (2014) 3 1 1 2 2 2 2 
Sung et al. (2016) 2 1 1 2 3 1 2 
Lim et al. (2017) 2 1 1 2 1 1 1 
Torabian et al. (2013) 2 1 1 2 1 3 2 
Yucel and Uysal (2015) 2 1 3 2 1 2 2 
 Table 1 - Quality assessment based on the quality assessment tool for quantitative studies' criteria 
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Table 2 - Effects of Pilates in noncommunicable diseases- clinical outcomes (non-patient reported) and outcome measures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author 
(Year)/Country 
Study 
Design 
Participants Intervention Outcomes Outcome Measures Key Findings 
Tunar et al 
(2012)/Turkey 
RCT Type 1 
Diabetes: n=31  
 
Intervention: 
n=17; 
35%male; 
14.2±2.2yrs 
 
Control: 
n=14; 
64%male; 14.3 
± 1.8yrs  
Duration: 12 weeks 
Frequency: 40 min. supervised 3 days/wk 
Components EG: 
• warm-up and cool down - 5 min. 
• Pilates exercises 
o 8 exercises, 3 sets of 6 to 10 repetitions with 
30 s active rest for each exercise 
CG: Usual Care 
Flexibility  
 
Sit-and-reach (cm) 
 
EG: Pre 0.4±5.2; Post 8.4±5.2, p<0.001 
CG: Pre 1.5±6.3; Post 2.9±6.5, p>0.05 
ES=0.94 
 
Lower limb strength  Vertical jump test  
 Height (cm) EG: Pre 35.7±10.2; Post 39.2±10, p=0.003 
CG: Pre 42.1±8; Post 43.9±7.4, p>0.05 
ES=0.15 
 Modified Wingate test  
 Mean power (W) EG: Pre 362.2±177.8; Post 386.5±180.7, p<0.001 
CG: Pre 401±104; Post 407.5±114.1, p>0.05 
ES=0.10 
 Peak power (W) EG: Pre 491.2±236.5; Post 509.6±226.8, p=0.02  
CG: Pre 549.2±161.4; Post 519.3±133.2, p>0.05 
ES=0.20 
Metabolic parameters Metabolic analysis   
HbA1c (%)  EG: Pre 8.9±1.6; Post 8.8±1.5, p>0.05 
CG: Pre 9.2±2.1; Post 8.7±1.8, p>0.05 
ES=-0.19 
DID (u/kg) 
 
 EG: Pre 1.1±0.3; Post 1±0.2, p>0.05 
CG: Pre 1±0.2; Post 1±0.2, p>0.05 
ES=-0.35 
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HDL (mg/dl) 
 
 EG: Pre 53.9±11.5; Post 56.9±9.6, p>0.05 
CG: Pre 58±12.8; Post 64±17.1, p=0.046 
ES=-0.14 
LDL (mg/dl)  EG: Pre 87.4±18.1; Post 85.3±14.6, p>0.05 
CG: Pre 94.8±25.9; Post 99.1±32.8, p>0.05 
ES=-0.22 
T Col (mgl/dl)  EG: Pre 167.4±23.4; Post 167.5±25.8, p>0.05 
CG: Pre 195.6±62.3; Post 196.1±62.1, p>0.05 
ES=-0.01 
TG (mg/dl)  EG: Pre 85.9±40.2; Post 89.9±46.8, p>0.05 
CG: Pre 104.1±80.2; Post 95.1±57.5, p>0.05 
ES=-0.19 
Eygor et al 
(2010)/Turkey 
RCT Breast Cancer: 
n=41 
 
Intervention: 
n=27; 0%male; 
48.5±7.6yrs 
Control: 
n=15; 0%male; 
49.7±8.7yrs 
Duration: 8 weeks 
Frequency: 60 min. supervised and 20-30 
min. unsupervised 3 days/wk,  
Components EG:  
• warm-up and cool down 
o breathing and stretching exercises 
• Pilates exercises 
o 2 sets of 10 repetitions  
• education session - 30 min. 
Exercise tolerance 
 
 
6MWD (m) EG: Pre 496.3±47.1; Post 522.6±42.0, p=0.00 
CG: Pre 506.7±44.5; Post 466.0±32.9, p=0.02 
EG vs CG p<0.01 
ES=1.28 
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• unsupervised exercises from a booklet - 
once a day 
• unsupervised walk – 20 to 30 min. 
o 3days/wk 
• Components CG: 
• education session - 30 min. 
• unsupervised exercises from a booklet - 
once a day 
• unsupervised walk – 20 to 30 min. 
o 3days/wk 
Flexibility Modified sit-and-reach test 
(inches) 
 
 
EG: Pre 8.0±10.2; Post 8.9±7.3, p=0.25 
CG: Pre 5.0±4.4; Post 5.0±4.8, p=0.86 
EG vs CG p=0.21 
ES=0.09 
Zengin et al 
(2016)/Turkey 
RCT Breast Cancer:  
n=56 
 
PG: n=18; 
0%male; 
46.2 ± 11.2yrs 
 
CEG:  
n=18; 0%male; 
51.9 ± 8.0yrs  
 
HEG: 
n=19; 0%male;  
51.5 ± 13.8yrs 
Duration: 8 weeks 
Frequency: 45 min. supervised 3 days/wk 
Components PG: 
• Teaching of key elements of Pilates 
• Pilates-based mat exercises 
• Pilates-based theraband exercises 
 
Components CEG:  
• Stretching 
• ROM 
• Shoulder strengthening exercises  
• breathing exercises 
 
Duration: 8 weeks 
Frequency: 3 days/wk unsupervised 
Components HEG: 
Flexibility 
 
Goniometer (º) 
 
 
Shoulder flexion  PEG: Pre 150.8±12.3; Post 160.5±12.9, p=0.001 
CEG: Pre 149.2±9.6; Post 166.2±7.8, p<0.001 
HEG: Pre 147.3±22.6; Post 157.9±13.5, p=0.019 
PEG vs CEG vs HEG p=0.012 
ES=0.16 
 
Shoulder abduction 
 
 PEG: Pre 133.4±23.7; Post 153.1±20.8, p=0.002 
CEG: Pre 128.7±20.5; Post 155.3±13.7, p<0.001 
HEG: Pre 130.2±32.3; Post 145.9±24.5, p=0.002 
PEG vs CEG vs HEG p>0.05 
ES=0.11 
Shoulder internal rotation 
 
 PEG: Pre 71.7±8.2; Post 75.0±8.3, p=0.029 
CEG: Pre 67.8±9.2; Post 79.1±7.0, p<0.001 
HEG: Pre 68.4±12.5; Post 70.5±11.0, p=0.280 
PEG vs CEG vs HEG p=0.00 
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• Individual exercise program taught by a 
physiotherapist. 
o Stretching 
o ROM 
o Shoulder strengthening exercises  
o breathing exercises 
 
ES=0.17 
Shoulder external rotation 
 
 PEG: Pre 74.5±10.1; Post 80.8±10.0, p=0.007 
CEG: Pre 61.8±12.2; Post 75.9±9.5, p<0.001 
HEG: Pre 67.8±17.7; Post 74.6±13.3, p=0.055 
PEG vs CEG vs HEG p=0.002 
ES=0.21 
Shoulder strength Hand-held dynamometer (kgf)  
Flexion  PEG: Pre 4.9±1.2; Post 6.2±1.5, p=0.001 
CEG: Pre 5.1±1.4; Post 6.2±1.4, p=0.016 
HEG: Pre 4.2±1.1; Post 4.9±1.6, p=0.041 
PEG vs CEG vs HEG p=0.019 
ES=0.14 
Abduction  PEG: Pre 4.5±1.3; Post 5.7±1.6, p=0.001 
CEG: Pre 4.5±1.1; Post 5.5±1.5, p=0.010 
HEG: Pre 3.9±1.1; Post 4.4±1.3, p=0.036 
PEG vs CEG vs HEG p > 0.05 
ES=0.10 
Internal rotation  PEG: Pre 6.5±1.8; Post 7.6±1.1, p=0.015 
CEG: Pre 5.8±2.2 Post 7.0±2.0, p=0.036 
HEG: Pre 5.7±1.7; Post 6.0±2.0, p=0.319 
PEG vs CEG vs HEG p> 0.05 
ES=0.10 
External rotation  PEG: Pre 6.1±1.7; Post 7.2±2.0, p=0.017 
CEG: Pre 6.0±1.9; Post 7.1±1.7, p=0.026 
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HEG: Pre 5.1±1.7; Post 5.3±1.8, p=0.542 
PEG vs CEG vs HEG p> 0.05 
ES=0.10 
Hand strength Hand-held dynamometer (kg)  
Grip  PEG: Pre 21.0±6.8; Post, NR p= 0.034 
CEG: Pre 19.3±5.3; Post, NR p= 0.031 
HEG: Pre 20.1±3.9, Post, NR p=0.027 
PEG vs CEG vs HEG p>0.05 
Lateral  PEG: Pre 3.9±2.2; Post, NR p= 0.012 
CEG: Pre 3.5±1.7; Post, NR p= 0.038 
HEG: Pre 3.6±1.9; Post, NR p=0.692 
PEG vs CEG vs HEG p>0.05 
Palmar  PEG: Pre 2.6±1.7; Post, NR p=0.016 
CEG: Pre 2.5±1.5; Post, NR p=0.022 
HEG: Pre 1.9±1.5; Post, NR p=0.239 
PEG vs CEG vs HEG p>0.05 
Tip  PEG: Pre 1.9±1.4; Post, NR p=0.023 
CEG: Pre 1.2±0.8; Post, NR p=0.074 
HEG: Pre 1.5±1.2; Post, NR p=0.521 
PEG vs CEG vs HEG p>0.05 
Functional status  Constant–Murley score* PEG: Pre 56.5±10.7; Post 72.2±6.7, p<0.001 
CEG: Pre 54.8±9.6; Post 69.7±11.7, p<0.001 
HEG: Pre 57.2±13.9; Post 60.1±12.0, p=0.157 
PEG vs CEG vs HEG p<0.001 
ES=0.24 
Sener et al 
(2017)/Turkey 
RCT Breast Cancer 
n=60 
 
Duration: 8 weeks 
Frequency: 3 days/wk 
Components EG: 
Handgrip strength  Handgrip dynamometer (kg) EG: Pre 17.5±6.7; Post 19.8±6.2, p=0.01 
CG: Pre 20.7±6.6; Post 21.9±5.4, p=0.08 
EG vs CG p=0.05 
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Intervention: 
n=30; 0%male; 
53.2±7.7yrs 
Control: 
n=30; 0%male;  
54.0±12.6yrs 
• Pilates exercises 
• Home program – every day 
o manual lymphatic drainage training, wall 
extension, and Wand exercises 
Components CG: 
• Core stabilization exercises 
• Home program – every day 
o Daily living activities with core protection 
o manual lymphatic drainage 
o shoulder exercises 
o skin care 
 
ES=0.14 
Flexibility Goniometer (º)  
Shoulder flexion  EG: Pre 165.3±21.5; Post 179.2±2.7, p=0.01 
CG: Pre 172.7±14.1; Post 177.5±6.4, p=0.08 
EG vs CG p=0.19 
ES=0.51 
Shoulder abduction 
 
 EG: Pre 155.5±35.7; Post 177.2±7.4, p=0.01  
CG: Pre 163.7±25.9; Post 173.5±16.6, p=0.01 
EG vs CG p=0.27 
ES=0.38 
Shoulder external rotation  EG: Pre 77.2±22.7; Post 88.67±3.5, p=0.05 
CG: Pre 81.8±15.0; Post 85.7±10.7, p=0.22 
EG vs CG p=0.15 
ES=0.39 
Cancelliero-Gaiad 
et al (2014)/Brazil 
RCT COPD: 
n=15 
Healthy: 
n=15 
 
Intervention: 
n=15; 
53%male; 
65.3±7.3yrs 
 
Control:  
Duration: 7 repetitions 
Frequency: 1 
Intervention for all participants: 
• breathing exercises – 7 repetitions 
o natural breathing 
o diaphragmatic breathing 
o Pilates breathing 
Respiratory pattern  Inductive plethysmography  
Inspiratory tidal volume 
(mL) 
 EG: NB 397.9±125.3, DB 880.5±421.4 (p<0.05); PB  
591.4±377.5 (p<0.05) 
CG:  NB 361.9±145.4; DB 1347.8±524.3 (p<0.05); PB 
948.6±439.3 (p<0.05) 
EG vs CG p<0.05 
ES NB=0.26; ES DB=0.00; ES PB=0.87 
Expiratory tidal volume 
(mL) 
 EG: NB 400.9±128.7; DB 881.7±426.4 (p<0.05); PB 
533.5±291.3 (p<0.05) 
CG: NB 368.3±145.2; DB 1420.5±584.3 (p<0.05); PB 
993.0±457.9 (p<0.05) 
EG vs CG p<0.05 
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n=15; 
47%male; 
62.5±9.4yrs 
 
ES NB=0.24; ES DB=1.05; ES PB=1.20 
 
Minute ventilation (L/min)  EG: NB 6.0±2.4; DB 9.8±2.5 (p<0.05); PB 8.9±4.3 
(p>0.05) 
CG: NB 5.6±1.8; DB 13.6±5.6 (p<0.05); PB 14.4±4.7 
(p<0.05) 
EG vs CG p>0.05  
ES NB=0.19; ES DB=0.88; ES PB=1.22 
 
 
 
 
 
 
 
  
 
 Respiratory rate (cpm) 
 
 EG: NB 16.7±3.8; DB 11.0±3.5 (p<0.05); PB 16.9±7.4 
(p<0.05) 
CG: NB 16.4±3.7; DB 11.8±4.8 (p<0.05); PB 16.2±3.4 
(p<0.05) 
EG vs CG p>0.05 
ES NB=0.08; ES DB=0.19; ES PB=0.12 
Inspiratory time (s)  EG: NB 1.3±0.3; DB 1.9±0.4 (p<0.05); PB 1.4±0.3 
(p<0.05) 
CG: NB 1.4±0.4; DB 2.9±0.9 (p<0.05); PB 1.8±0.4 
(p<0.05) 
EG vs CG p<0.05  
ES NB=0.28; ES DB=1.44; ES PB=1.13 
Expiratory time (s)  EG: NB 2.9±1.3; DB 4.5±2.0 (p<0.05); PB 2.7±0.9 
(p<0.05) 
CG:  NB 2.3±0.5; DB 5.2±1.8 (p<0.05); PB 2.5±0.6 
(p<0.05) 
EG vs CG p>0.05 
ES NB=0.61; ES DB=0.37; ES PB=0.26 
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Total breath time (s) 
 
 EG: NB 4.2±1.5; DB 6.4±2.1 (p<0.05); PB 4.1±1.1 
(p<0.05) 
CG: NB 3.7±0.8; DB 8.1±2.5 (p<0.05); PB 4.2±0.9 
(p<0.05) 
EG vs CG p>0.05 
ES NB=0.42; ES DB=0.74; ES PB=0.10 
%RCi 
 
 EG: NB 54.5±28.1; DB 50.6±48.4; PB 61.1±28.2 
(p>0.05) 
CG: NB 63.3±16.3; DB 66.7±15.5; PB 80.9±18.3 
(p<0.05) 
EG vs CG p>0.05 
ES NB=0.38; ES DB=0.45; ES PB=0.83 
 
Labored breathing index  
 
 
 
 
 
 
EG: NB 1.1±0.3; DB 1.2±0.3; PB 1.0±0.0, p>0.05 
CG: NB 1.0±0.0; DB 1.1±0.1; PB 1.1±0.1, p>0.05 
EG vs CG p>0.05 
ES NB=0.47; ES DB=0.45; ES PB=1.41 
Phase relation during 
inspiration 
 
 
EG: NB 13.5±12.9; DB 38.8±21.6 (p<0.05); PB 
21.4±10.5 (p<0.05), 
CG: NB 5.7±3.0; DB 29.6±14.6 (p<0.05); PB 
25.8±12.3 (p<0.05) 
EG vs CG p<0.05 in favor of NB 
ES NB=0.83; ES DB=0.50; ES PB=0.38 
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Phase relation during 
expiration 
 
 EG: NB 13.9±8.0; DB 37.1±19.0 (p<0.05); PB 
21.7±9.8 (p<0.05) 
CG: NB 5.8±2.7; DB 30.7±14.2 (p<0.05); PB 
28.0±10.1 (p<0.05) 
EG vs CG p<0.05 in favor of NB 
ES NB=1.36; ES DB=0.38; ES PB=0.63 
 
Phase relation of the entire 
breath 
 
 EG: NB 13.4±8.0; DB 37.2±19.6 (p<0.05); PB 
22.1±9.5 (p<0.05) 
CG: NB 5.7±2.5; DB 26.8±12.7 (p<0.05); PB 
26.2±10.4 (p<0.05) 
EG vs CG p<0.05 in favor of NB 
ES NB=1.30; ES DB=0.63; ES PB=0.41 
 
Phase angle (º) 
 
 EG: NB 24.1±22.1; DB 67.0±47.7 (p<0.05); PB 
30.6±12.3 (p<0.05) 
CG: NB 9.1±4.2; DB 39.1±19.1 (p<0.05); PB 21.1±9.5 
(p<0.05) 
EG vs CG p<0.05 
ES NB=0.94; ES DB=0.77; ES PB=0.86 
 SpO2 (%)  Oximetry EG: NB 95.4±3.4; DB 99.4±1.4 (p<0.05); PB 99.3±1.6 
(p<0.05) 
CG: NB 97.4±1.6; DB 99.7±0.7 (p<0.05); PB 99.5±0.8 
(p<0.05) 
EG vs CG p>0.05 
ES NB=0.75; ES DB=0.27; ES PB=0.16 
   
Cystic Fibrosis: 
 
Duration: 16 weeks 
 
MIP  
 
Respiratory pressures (cmH2O) 
 
M: Pre 77.9±19.5; Post 101.4±22.7, p=0.017 
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Franco et al 
(2014)/Brazil 
1 group 
pre-post 
design 
n=19 
37%male; 
13.7 ± 7.4yrs 
 
Frequency: 60 min. individual session once 
a week,  
Components:  
• respiratory, postural, and abdominal 
exercises 
• strength exercises for the trunk, upper 
limbs, and lower limbs 
  F: Pre 70.8±19.2; Post 92.5±17.3, p=0.005 
ES (M)=0.11, ES (F)=1.19 
 
MEP 
 
  
M: Pre 67.9±18.9; Post 85.0±17.3, p=0.106 
F: Pre 67.1±14.5; Post 81.7±18.7, p=0.007 
ES (M)=0.94, ES (F)=0.87 
Lung volumes Spirometry (%)  
FEV1 
 
 M: Pre 69.2±18.6; Post 71.1±18.4, p=0.598 
F: Pre 69.5±25.7, Post 71.5±26.6, p=0.555 
ES (M)=0.10, ES (F)=0.08 
FVC   M: Pre 78.2±17.6; Post 76.8±13.3, p=0.463 
F: Pre 80.1±22.4, Post 81.4±27.2, p=0.964 
ES (M)=0.09, ES (F)=0.05 
Guimarães et al 
(2012)/Brazil 
RCT Heart failure: 
n=16 
 
Intervention: 
n=8; 62%male; 
46±12yrs 
 
Control:  
n=8; 81%male; 
44±11yrs 
 
Duration: 16 weeks 
Frequency: 60 min. group session 2days/wk 
Components:  
• warm-up and cool down -10 min. 
• aerobic exercise – 30 min. 
o walking on treadmill 
• Pilates mat exercises – 20 min. 
o strengthening, stretching, ROM, and 
balance exercises 
Components CG: 
• warm-up and cool down -10 min. 
• aerobic exercise – 30 min. 
o walking on treadmill 
• flexibility exercise 
• resistance exercise 
Vital signs  CPET  
HR rest (bpm)   EG: Pre 78±17; Post 76±13, p>0.05 
CG: Pre 72±18; Post 71±18, p>0.05 
ES= -0.05 
HR max (bpm) 
 
 EG: Pre 135±27; Post 144±24, p>0.05 
CG: Pre 125±23; Post 125±18, p>0.05 
ES= -0.32 
SBP rest (mmHg) 
 
 EG: Pre 106±16; Post 101±24, p>0.05 
CG: Pre 113±24; Post 108±17, p>0.05 
ES= 0.00 
SBP max (mmHg) 
 
 EG: Pre 125±17; Post 143±21, p>0.05 
CG: Pre 134±21; Post 127±18, p>0.05 
ES= -1.05 
DBP rest (mmHg) 
 
 EG: Pre 73±14; Post 67±17, p=0.02 
CG: Pre 69±9; Post 67±12, p>0.05 
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o 1 set of 10–15 repetitions of 8–10 exercises 
• calisthenics 
ES= -0.24 
DBP max (mmHg) 
 
 EG: Pre 68±19; Post 69±13, p>0.05 
CG: Pre 64±15; Post 64±21, p>0.05 
ES= -0.05 
Exercise tolerance CPET  
Peak VO2 (mlO2 /kg/min) 
 
 EG: Pre 20.9±6.6; Post 24.8 ± 6.0, p=0.001 
CG: Pre 17.4±3.9; Post 18.3 ± 4.2, p>0.05 
ES= 0.46, p=0.02 
Pulse O2 (mlO2/bpm) 
 
 EG: Pre 11.9±3; Post 13.8±3, p=0.003 
CG: Pre 11.6±4; Post 12±4, p>0.05 
ES= 0.35 
RER 
 
 EG: Pre 1.1±0.1; Post 1.1±0.1, p>0.05 
CG: Pre 1.1±0.1; Post 1.1±0.1, p>0.05 
ES= 0.00 
VE/VCO2 
 
 EG: Pre 29±5; Post 29±4, p>0.05 
CG: Pre 31±6; Post 32±6, p>0.05 
ES= 0.15 
Time (minutes)  EG: Pre 12.8±2.5; Post 17.8±4, p< 0.001 
CG: Pre 11.7±3.9; Post 14.2±4, p>0.05 
ES= 0.55 
Martins-Meneses 
et al (2014)/Brazil 
CCT Hypertension 
n=44 
 
Intervention: 
n=22 
Duration: 16 weeks 
Frequency: 60 min group session 2days/wk 
Components:  
• warm-up and cool down – 20 min. 
Flexibility  
 
Bank of wells test (cm) 
 
EG: Pre 25.7±8.4; Post 30.0±7.4, p<0.05 
CG: Pre 22.5±9.2; Post 22.4±9.4, p>0.05 
ES=0.42, p<0.05 
Handgrip strength Handgrip dynamometer (kg) 
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0%male; 
51.8±4.3yrs 
 
Control: 
n=22 
0%male; 
49.0±7.5yrs 
• Pilates mat exercises – 40 min. 
o strengthening, stretching, range of motion, 
and balance exercises 
Components CG: Usual Care 
 
Right hand  EG: Pre 27.3±5.6; Post 30.4±4.6, p<0.05 
CG: Pre 27.6±6.0; Post 27.2±5.8, p>0.05 
ES=0.52, p<0.05 
Left hand  EG: Pre 26.0±6.2; Post 29.8±5.3, p<0.05 
CG: Pre 25.9±5.8; Post 25.3±5.6, p>0.05 
ES=0.63, p<0.05 
Body composition Anthropometric tape  
BM (kg) 
 
EG: Pre 79.0±14.8; Post 78.7±15.0, p>0.05 
CG: Pre 79.1±17.3; Post 79.9±17.2, p>0.05 
ES=-0.06, p>0.05 
BMI (kg/m2) 
 
EG: Pre 30.0±4.7; Post 29.6±4.8, p>0.05 
CG: Pre 30.2±6.3; Post 30.5±6.3, p>0.05 
ES=-0.1, p>0.05 
Waist circumference (cm) 
 
EG: Pre 93.2±13.5; Post 89.9±13.2, p<0.05 
CG: Pre 93.5±16.0; Post 95.0±14.4, p>0.05 
ES=-0.27, p<0.05 
Hip circumference (cm) 
 
EG: Pre 110.8±11.0; Post 107.9±10.1, p<0.05 
CG: Pre 109.0±14.1; Post 110.7±12.7, p>0.05 
ES=-0.31, p<0.05 
Vital signs Oscillometric device (24h)   
SBP (mmHg)  EG: Pre 125.6±18.3; Post 118.5±10.3, p<0.05 
CG: Pre 122.2±11.4; Post 125.1±13.4, p>0.05 
ES=-0.59, p<0.05 
DBP (mmHg) 
 
 EG: Pre 78.2±14.2; Post 74.9±9.4, p<0.05 
CG: Pre 76.5±8.4; Post 77.8±10.0, p>0.05 
ES=-0.35, p<0.05 
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MBP (mmHg) 
 
 EG: Pre 94.0±15.3; Post 89.4±9.4, p<0.05 
CG: Pre 91.8±8.9; Post 93.6±10.7, p>0.05 
ES=-0.45, p<0.05 
HR (bpm)  
 
EG: Pre 73.5±8.6; Post 75.7±9.1, p>0.05 
CG: Pre 78.9±10.6; Post 78.0±10.1, p>0.05 
ES=-0.26, p>0.05 
DP (bpm x mmHg)  EG: Pre 9263.3±1939.4; Post 8983.6±1376.4, 
p>0.05 
CG: Pre 9646.8±1592.6; Post 9775.6±1643.0, 
p>0.05 
ES=-0.2, p>0.05 
Sung et al 
(2016)/Republic 
of Korea 
RCT Stroke: n=19  
Intervention: 
n=10; 
50%male; 
66.8±5.7yrs  
Control: 
n=9; 56%male; 
61.1±6.6yrs  
 
Duration: 8 weeks 
Frequency: 60 min. supervised 3 days/wk, 
Components EG: 
• warm-up and cool down 
• breathing exercises  
• Pilates exercises 
o 1 set of 8 repetitions 
• mobility and strengthening exercises  
• other exercises 
o Charlie Chaplin exercises, swimming, heel 
squeeze and prone bridge 
CG: Usual Care 
Static balance Treadmill  
Medial-lateral COP (mm) 
 
 EG: Pre 10.9±5.0; Post 7.1±2.2, p<0.05 
CG: Pre 11.7±5.4; Post 16.1±6.1, p>0.05 
ES=-1.36, p<0.05 
Anterior-posterior COP 
(mm) 
 
 EG: Pre 14.8±8.0; Post 10.5±3.7, p<0.05 
CG: Pre 16.1±6.1; Post 16.8±5.0, p>0.05 
ES=-0.67, p<0.05 
Medial-lateral velocity 
(mm/s) 
 EG: Pre 83.9±42.1; Post 66.5±26.6, p<0.05 
CG: Pre 84.2±45.0; Post 86.7±41.9, p>0.05 
ES=-0.41, p<0.05 
Anterior-posterior velocity 
(mm/s) 
 
 EG: Pre 122.0±47.6; Post 104.5±42.0, p<0.05 
CG: Pre 130.5±45.8; Post 135.8±43.2, p>0.05 
ES=-0.42, p<0.001 
Dynamic balance (Paretic 
Side) 
  
Medial-lateral COP (mm)  
 
 EG: Pre 15.0±2.1, Post 12.0±1.4, p<0.01 
CG: Pre 16.0±2.4; Post 16.3±2.4, p>0.05 
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ES=-1.28, p<0.05 
Anterior-posterior COP 
(mm) 
 
 
 
EG: Pre 27.0±3.2; Post 22.4±2.7, p<0.001 
CG: Pre 26.2±3.7; Post 26.5±2.9, p>0.05 
ES=-1.27, p<0.001 
Medial-lateral velocity 
(mm/s)  
 
 EG: Pre 88.6±33.5; Post 76.5±25.6, p<0.05 
CG: Pre 91.8±39.8; Post 92.6±38.8, p>0.05 
ES=-0.3, p<0.001 
Anterior-posterior velocity 
(mm/s) 
 EG: Pre 114.8±31.2; Post 98.3±25.2, p<0.01 
CG: Pre 117.0±30.6; Post 117.1±29.1, p>0.05 
ES=-0.46, p<0.001 
Dynamic balance (non-
paretic Side) 
  
Medial-lateral COP (mm)  EG: Pre 12.7±1.2; Post 10.4±0.8, p<0.001 
CG: Pre 13.7±2.2; Post 14.2±1.9, p>0.05 
ES=-1.43, p<0.001 
Anterior-posterior COP 
(mm) 
 
 
EG: Pre 23.2±2.4; Post 18.2±1.2, p<0.001 
CG: Pre 22.1±3.6; Post 22.9±3.3, p>0.05 
ES=-1.71, p=<0.001 
Medial-lateral velocity 
(mm/s)  
 
 EG: Pre 79.0±28.3; Post 66.5±21.2, p<0.05 
CG: Pre 86.0±27.2; Post 87.2±26.3, p>0.05 
ES=-0.43, p<0.001 
Anterior-posterior velocity 
(mm/s) 
 EG: Pre 89.7±28.8; Post 73.2±17.9, p<0.05 
CG: Pre 96.9±27.5; Post 97.0±25.1, p>0.05 
ES=-0.53, p<0.01 
Lim et al 
(2017)/Republic 
of Korea 
RCT Stroke: n=20 
Intervention: 
n=10 
Duration: 8 weeks 
 
Components EG: 
Functional status TUG (seconds) 
 
EG: Pre 22.6±5.7; Post 19.2±5.8, p<0.05 
CG: Pre 19.2±5.4, Post 21.7±6.4, p<0.05 
EG vs CG p<0.05 
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60%male; 
63.2±7.9yrs 
 
Control: 
n=10 
50%male; 
62.1±6.7yrs 
 
 
Frequency: 60 min. supervised 3 days/wk 
• breathing exercises  
• Pilates exercises 
o 8 sets 
o spine mobility exercises 
o upper limb exercises 
o lower limb strengthening exercises 
EG and CG: conventional stroke 
rehabilitation program 30 min 5 days/wk 
for 8 weeks 
• joint mobility 
• muscle strengthening 
• walking exercise 
ES=-0.82 
Vital signs CPET  
HR rest (bpm) 
 
 EG: Pre 84.1±16.6; Post 76.5±14.5, p<0.05 
CG: Pre 83.3±17.3, Post 85.4±16.6, p<0.05 
EG vs CG p<0.05 
ES=-0.49 
 
Exercise tolerance CPET  
VO2 max (ml/min)  EG: Pre 819.3±251.4; Post 964.8±244.2, p<0.05 
CG: Pre 1048.8±420.5, Post 1027.3±416.5, p<0.05 
EG vs CG p<0.05 
ES=0.40 
 
VO2 max per kg (ml/kg/min)  EG: Pre 12.1±2.9; Post 14.3±2.5, p<0.05 
CG: Pre 14.7±4.7, Post 14.4±4.7, p<0.05 
EG vs CG p<0.05 
ES=0.53 
 
Data are presented as mean±standard deviation;  
NCDs: Noncommunicable diseases; RCT: Randomized control trial; EG: Experimental group; CG: Control group; ES: Effect size; HbA1c:  Glycated haemoglobin; DID: Daily insulin doses; HDL: High density lipoprotein; LDL: Low density lipoprotein; T 
col: Total cholesterol; TG: Triglyceride; 6MWT: 6-minute walk test; 6MWD: 6-minute walk distance; PG: Pilates group; CEG: Combined exercise group; HEG: Home exercise group; NR: not reported. Authors were contacted and did not reply; ROM: 
Range of motion; NB: Natural breathing; DB: Diaphragmatic breathing; PB: Pilates breathing; %RCi: Percent rib cage inspiratory contribution to tidal volume ratio; SpO2: Peripheral oxygen saturation; M: Male; F: Female; MIP: Maximum Inspiratory 
Pressure; MEP: Maximum Expiratory Pressure; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; CPET: Cardiopulmonary exercise test; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; VO2: oxygen 
consumption; RER: Respiratory exchange ratio; VE/VCO2: Minute ventilation − carbon dioxide production relationship; CCT: Non randomized controlled clinical trial; BM: Body mass; BMI: Body mass index; MBP: Mean blood pressure; DP: Double 
product; COP: centre of pressure. 
* Constant Murley score is a mixed measure but it was allocated to clinical outcomes as they account for 65 points out of 100 points of the measure. 
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 Table 3 - Effects of Pilates in noncommunicable diseases - patient reported outcomes (PROs) and outcome measures 
Author 
(Year)/Country 
Study 
Design 
Participants Intervention Measures Outcome Measures Key Findings 
Torabian et al 
(2013)/Iran 
2 groups 
pre-post 
design 
Type 2 
Diabetes: 
n=70 
 
Intervention: 
n=35; 0%male 
[30-70] yrs 
 
Control: 
n=35; 0%male 
[30-70] yrs 
Duration: 8 weeks 
Frequency: 60 min. supervised 2d/wk 
Components EG:  
• warm-up and cool down - 5 min. 
o stretching exercises 
• Pilates exercises - 50 min. 
o 10 to 80 repetitions 
CG: Usual Care 
Symptoms GHQ-28  
Physical symptoms  EG: Pre 43.1±2.1; Post 4.3±1.8, p=0.001 
CG: Pre 12.2±3.1; Post 11.9±2.7, p=0.23 
EG vs. CG p=0.01 
ES=-12.70 
Anxiety 
 
 EG: Pre 11.0 ±2.0; Post 5.9±2.2, p=0.04 
CG: Pre 10.6±3.3; Post 0.7±2.6, p=0.11 
EG vs. CG p= 0.003 
ES= -1.52 
Depression  EG:  Pre 11.1±2.6; Post 6.4±2.0, p=0.01 
CG: Pre 11.5±2.9; Post 11.3±3.0, p=0.47 
EG vs. CG p=0.04 
ES=-1.38 
Social dysfunction GHQ-28 EG: Pre 13.0±2.3; Post 6.2±2.2, p=0.02 
CG: Pre 12.4±3.5; Post 11.5±2.9, p=0.50 
EG vs. CG p=0.001 
ES= -1.73 
Total score  EG: Pre 47.2±9.1; Post 22.8±8.2, p=0.002 
CG: Pre 46.6±12.9; Post 45.5±11.0, p=0.24 
EG vs CG p= 0.003 
ES= -1.82 
Yucel and Uysal 
(2015)/Turkey 
RCT Type 2 
diabetes: n=45 
 
Duration: 12 weeks 
Frequency: 45 to 70 min. supervised 3 
days/wk 
Symptoms VAS  
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Intervention: 
n=24; 0%male; 
58.5±7yrs 
 
Control: 
n=21; 0%male; 
53.5± 9yrs 
Components EG: 
• warm-up and cool down 
• stretching exercises;  
• basic aerobic pilates 
CG: Usual Care 
Pain  EG: Pre 3.0±4.0; Post 2.0±2.0, p=0.001 
CG: Pre 3.0±3.0; Post 3.0±2.0, p=0.308 
ES=-0.27 
Fatigue  EG: Pre 5.0±2.0; Post 4.0±1.0, p=0.001 
CG: Pre 4.50±1.0; Post 4.0±2.0, p=0.42 
ES=-0.25 
Symptoms SF-36  
Mental health  EG: Pre 29.0±5.0; Post 35.0±3.0, p=0.001 
CG: Pre 29.0±11.0; Post 35.0±1.0, p=0.132 
ES=0.00 
Physical Health 
 
 EG: Pre 40.0±3.0; Post 41.0±4.0, p=0.120 
CG: Pre 40.0±0.0; Post 41.0±4.0, p=0.42 
ES=0.00 
Symptoms  HADS  
Anxiety  EG: 8.0±3.0; Post 7.0±3.0, p=0.023 
CG: Pre 8.0±1.0; Post 7.0±1.0, p=0.162 
ES=0.00 
Depression  EG: Pre 9.0±2.0; Post 8.0±2.0, p=0.019 
CG: Pre 9.0±2.0; Post 8.0±1.0, p=0.08 
ES= 0.00 
Eygor et al 
(2010)/Turkey 
RCT Breast Cancer: 
n=41 
 
Intervention: 
n=27; 0%male; 
48.5±7.6yrs 
Control: 
Duration: 8 weeks 
Frequency: 60 min. supervised and 20-30 
min. unsupervised 3 days/wk,  
Components EG:  
• warm-up and cool down 
o breathing and stretching exercises 
• pilates exercises 
o 2 sets of 10 repetitions  
• education session - 30 min. 
Symptoms   
Fatigue 
 
BFI EG: Pre 6.6±4.1; Post 5.6±4.7, p= 0.14 
CG: Pre 7.7±5.7; Post 6.5±4.4, p=0.82 
EG vs CG p= 0.66 
ES= -0.03 
Depression BDI 
 
 
EG: Pre 7.4±5.8; Post 5.6±6.4, p= 0.01 
CG: Pre 9.5±12.1; Post 6.8±9.5, p=0.25 
EG vs CG p=0.47 
ES=-0.09 
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n=15; 0%male; 
49.73±8.7yrs 
• unsupervised exercises from a booklet - 
once a day 
• unsupervised walk – 20 to 30 min. 
o 3days/wk 
Components CG: 
• education session - 30 min. 
• unsupervised exercises from a booklet 
- once a day 
• unsupervised walk – 20 to 30 min. 
o 3days/wk 
Quality of life EORTC QLQ-C30  
Functional QoL  EG: Pre 77.1±15.0; Post 83.3±14.7, p=0.03 
CG: Pre 76.7±21.7; Post 78.0±20.5, p=0.53 
EG vs CG p=0.33 
ES=0.23 
Symptoms QoL 
 
 EG: Pre 19.0±12.2; Post 20.9±21.5, p=0.43 
CG: Pre 23.2±23.9; Post 13.2±10.0, p= 0.21 
EG vs CG p=0.48 
ES=0.53 
Global QoL 
 
 EG: Pre 70.2±20.6; Post 77.0±21.8, p=0.19 
CG: Pre 62.6±29.3; Post 63.8±23.8, p=0.91 
EG vs CG p=0.79 
ES=0.20 
Quality of life EORTC QLQ-BR23  
Functional QoL  EG: Pre 77.8±16.6; Post 84.4±10.5, p= 0.04 
CG: Pre 73.27±20.1; Post 75.8±10.6, p=0.85 
EG vs CG p=0.26  
ES=0.22 
Symptoms QoL  EG: Pre 21.1±15.3; Post 17.4±18.2, p=0.20 
CG: Pre 23.0±20.2; Post 19.0±10.6, p=0.18 
EG vs CG p=0.31 
ES=0.01 
Zengin et al 
(2016)/Turkey 
RCT Breast Cancer:  
n=56 
 
PEG: n=18; 
0%male; 
46.2 ± 11.2yrs 
 
Duration: 8 weeks 
Frequency: 45 min. supervised 3 days/wk 
Components PG: 
• teaching of key elements of Pilates 
• Pilates-based mat exercises 
• Pilates-based theraband exercises 
 
Symptoms VAS  
Pain in motion  PEG: Pre 5.0±2.0; Post 1.7±1.6, p <0.001 
CEG: Pre 4.6±1.6; Post 1.3±1.7, p<0.001 
HEG: Pre 4.3±2.2; Post 2.1±2.3, p<0.001 
PEG vs CEG vs HEG p=0.109 
ES=0.08 
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CEG:  
n=18; 0%male; 
51.9 ± 8.0yrs  
 
HEG: 
n=19; 0%male;  
51.5 ± 13.8yrs 
Components CEG:  
• Stretching 
• ROM 
• Shoulder strengthening exercises  
• breathing exercises 
 
Duration; 8 weeks 
Frequency: 3days/wk unsupervised 
Components HEG: 
• Individual exercise program taught by a 
physiotherapist. 
o Stretching 
o ROM 
o Shoulder strengthening exercises  
o breathing exercises 
Pain at rest  PEG: Pre 2.6±2.5; Post 0.5±1.0, p=0.004 
CEG: Pre 1.6±1.8; Post 0.2±0.6, p=0.002 
HEG: Pre 2.0±2.3; Post 0.2±0.7, p=0.005 
PEG vs CEG vs HEG p=0.897 
ES=0.0 
Functional status  DASH PEG: Pre 38.8±17.2; Post 23.8±13.4, p<0.001 
CEG: Pre 31.4±11.9; Post 19.4±12.0, p<0.001 
HEG: Pre 38.9±20.1; Post 32.1±20.2, p=0.046 
PEG vs CEG vs HEG p=0.002 
ES=0.21 
Sener et al 
(2017)/Turkey 
RCT Breast Cancer 
n=60 
 
Intervention: 
n=30; 0%male; 
53.2±7.7yrs 
Control: 
n=30; 0%male;  
54.0±12.6yrs 
Duration: 8 weeks 
Frequency: 3 days/wk 
Components EG: 
• Pilates exercises 
• Home program – every day 
o manual lymphatic drainage 
training, wall extension, and Wand 
exercises 
Components CG: 
• Core stabilization exercises 
• Home program – every day 
o Daily living activities with core 
protection 
o manual lymphatic drainage 
Symptoms   
Pain VAS EG: Pre 3.5±3.2; Post 0.7±0.8, p<0.01 
CG: Pre 2.3±3.3; Post 0.9±1.4, p=0.02 
EG vs CG p=0.51 
ES=-0.44 
Anxiety 
 
SAA 
 
EG: Pre 24.8±8.0; Post 19.7±3.7, p <0.01 
CG: Pre 27.6±9.1; Post 26.2±8.1, p=0.04 
EG vs CG p<0.01 
ES=-0.40 
Quality of life EORTC QLQ-BR23 
 
EG: Pre 32.4±10.2; Post 38.5±8.4, p=0.04 
CG: Pre 34.1±9.6; Post 38.4±7.5, p=0.02 
EG vs CG p=0.94 
ES=0.16 
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o shoulder exercises 
o skin care 
Functional status  DASH EG: Pre 44.2±15.3; Post 38.0±15.0, p <0.01 
CG: Pre 34.8±12.0; Post 32.2±12.1, p <0.01 
EG vs CG p=0.39 
ES=-0.21 
Data are presented as mean±standard deviation 
EG: Experimental group; CG: Control group;  ES: Effect size; GHQ-28: General health questionnaire – 28; VAS: Visual analogue scale; SF-36: 36-item short-form health survey; HADS: Hospital anxiety depression scale; BFI: Brief fatigue inventory; 
BDI: Beck depression index; EORTC QLQ-C30: European organization for the research and treatment of cancer quality of life questionnaire; QoL: quality of life; EORTC QLQ-BR23:  European organization for the research and treatment of cancer 
quality of life questionnaire breast cancer module 23; DASH: Disabilities of the arm, shoulder, and hand scale; PEG: Pilates exercice group; CEG: combined exercise group; HEG: home exercise group; SAA: Social appearance anxiety (SAA) Scale 
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Table 4 -Best-evidence synthesis of the effects of Pilates in noncommunicable diseases 
HRQoL: Health-related quality of life 
Level of evidence: 1 – strong; 2 – moderate; 3 – limited; 4 – conflicting; 5 – no evidence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outcome Studies Level of evidence Direction of effect 
Symptoms 70, 71, 74, 75, 79 2 Pilates equal to other interventions 
Vital signs 72, 76, 78, 80 4 conflicting evidence 
Metabolic parameters 81 3 Pilates equal to usual care 
Body composition 76 3 favours Pilates 
Muscle strength 71, 73, 76, 79, 81 2 Pilates equal to other interventions but favours Pilates over usual care 
Respiratory function 72, 73 3 Pilates equal to other interventions 
Functional Status 71, 79, 80 4 conflicting evidence 
Exercise tolerance 70, 78, 80 1 favours Pilates 
Balance 77 3 favours Pilates 
Flexibility 70, 71, 76, 79, 81 4 conflicting evidence 
HRQoL 70, 79 2 Pilates equal to other interventions 
Social support 75 3 favours Pilates 
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Appendix 1 1 
 2 
The following electronic databases were searched for potential studies: Cochrane Library 3 
(1999-2017), EBSCO (1974-2017), PubMed (1996-2017), Science Direct (1997-2017), Scopus 4 
(1960-2017) and Web of Science (1900-2017) on the 15th of November 2016. Additional 5 
searches were performed in weekly automatic updates retrieved from the databases until 6 
November 2017. The search terms used were organized using the PICOT (Population, 7 
Intervention, Comparison, Outcome and Time) framework102:  8 
 9 
P: Chronic respiratory diseases (COPD, asthma, cystic fibrosis, bronchiectasis); Chronic 10 
cardiovascular diseases (hypertension, heart failure, coronary artery disease, vascular disease, 11 
cardiac arrhythmias, stroke); diabetes; cancer. 12 
I: pilates; mat pilates; pilates method; pilates-based rehabilitation  13 
C: respiratory physiotherapy; respiratory physical therapy; physiotherapy; physical therapy; 14 
exercise; exercise training; pulmonary rehabilitation; respiratory rehabilitation; cardiac 15 
rehabilitation; breathing exercises; airway clearance techniques; strength; stretch; flexibility; 16 
balance; diaphragmatic breathing; physical activity; aerobic exercise; yoga; yogasana; tai-chi; 17 
walking; running; hiking; dancing; nordic-walking; hydrotherapy; swimming; meditation; 18 
psychoeducation; education and psychosocial support 19 
O: breathing pattern; lung volumes; respiratory rate; chest expansion; symptoms; dyspnea; 20 
fatigue; pain; depression; anxiety; neuromotor; function*; exercise tolerance; force; strength; 21 
functional capacity; balance; flexibility; body composition; health; quality of life; well-being  22 
T: not applicable  23 
 24 
Typical Search 25 
[(“chronic respiratory disease” OR “chronic lung disease” OR “COPD” OR “chronic obstructive 26 
pulmonary disease” OR “asthma” OR “cystic fibrosis” OR “chronic cardiovascular disease” OR 27 
“heart failure” OR “hypertension” OR “atherosclerosis” OR “coronary artery disease” OR 28 
“valvular disease” OR “cardiac arrhythmias” OR “stroke” OR “diabetes” OR “cancer”) AND 29 
(“breathing pattern” OR “respiratory pattern” OR “lung volume” OR “respiratory volume” OR 30 
“lung capacity“ OR “respiratory rate” OR “chest expansion” OR “thoracic expansion” OR “chest 31 
extension” OR “symptoms” OR “metabolic” OR “dyspnea” OR “dyspnoea” OR “fatigue” OR 32 
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“pain” OR “depression” OR “anxiety” OR “neuromotor” OR “function*” OR “functional 33 
capacity” OR “capacity” OR “exercise tolerance” OR “exercise capacity” OR “aerobic capacity” 34 
OR “aerobic tolerance” OR “resistance” OR “force” OR “strength” OR “balance” OR “flexibility” 35 
OR “stretch” OR “body composition” OR “BMI” OR “body mass index” OR “fat mass” OR 36 
“health” OR “quality of life” OR “life quality” OR “well-being” OR “questionnaire*” OR 37 
“interview*”) AND (“pilates” OR “pilates-based rehabilitation”)]. 38 
